Have You Heard of Doximity?

Doximity (NYSE: DOCS) is an online network platform for medical professionals that went public on June 24, 2021, and is trading up near 124% from its IPO price. Let’s take a brief look at the company and how it got where it is today. Doximity (NYSE: DOCS) is an online network platform for medical professionals that went public on June 24, 2021, and is trading up near 124% from its IPO price. Let’s take a brief look at the company and how it got where it is today. [Energy and Capital logo] Have You Heard of Doximity? By Monica Savaglia Written Jul 04, 2021 Doximity (NYSE: DOCS) went public two weeks ago, and the market is still raving about this new stock. The company was up 69% on the first day of trading from its IPO price of $26 per share. Doximity is being touted as the “LinkedIn for doctors” by the public. The company does describe itself as an online networking platform for medical professionals, so being called “LinkedIn for doctors” isn’t too far off. Its name is short for “doctors and proximity.” The company aims to connect medical professionals, aspiring doctors, and medical institutions under one platform. Doximity is based in San Francisco, California, and was founded back in 2010 by its current CEO Jeff Tangney, along with Nate Gross and Shari Buck. On Thursday, June 24, 2021, the company made its public debut on the New York Stock Exchange. It was able to close that week with a market capitalization near $10 billion, raising around $500 million in its IPO. Of course, this got the attention of many investors who wondered what Doximity was and why the company was surging on its public debut. Doximity wasn’t lumped into the list of billion-dollar tech companies. During its last funding round in 2014, the company was valued at under $400 million. Tangney said that because Doximity is profitable, it still hasn’t touched the $50 million it raised seven years ago. The company didn’t need the money it raised and didn’t need to have any more funding rounds over the past seven years because it was making a profit. [QUIZ] Most Investors Get This Wrong What do you think is about to kill Tesla? ([Skip ahead for the answer.]() - [Elon Musk’s tweets]( - [SEC]( - [Chinese competitor NIO]( - [Off-the-radar fuel (NOT hydrogen)]( No matter what you pick, when you really think about it, the answer isn’t actually that surprising. Make your selection to find out! Tangney said in an interview after ringing the bell at the NYSE: I did resist some of the Silicon Valley wisdom of, you need to go big, you need to hire 40 more salespeople and do all these things. He added: The reality of health care and our clients, who are very staid institutions, a lot of nonprofits that have been around for 100 years, is that even if you lean in and hire tons of sales and marketing people, they’re not going to let you grow. Essentially, Tangney doesn’t believe that it would be worthwhile for Doximity to aim for massive growth if its target market accepts it. Most of the company’s revenue is earned from drugmakers. Forbes reports: According to Reuters, Doximity’s 1.8 million members represent 80% of U.S. doctors. Eighty percent of its revenue comes from advertisements paid by pharmaceutical companies and hospitals, with the remainder derived from recruiters and telehealth. Doximity doesn’t quite fit that Silicon Valley mold, and maybe that’s a good thing. Tangney also mentioned in the interview that the company isn’t inclined to pay for branding for the sake of building its profile. This could explain why the company has remained unknown to most investors and the investing world. Tangney believes that the best advertising has come from doctors who endorse Doximity’s product through their practitioner networks. Despite being low-key within the Silicon Valley world, Doximity has been able to stay profitable and maintain strong financials. Last fiscal year, it generated over $200 million in revenue and produced over $50 million in net income. Doximity’s platform for medical professionals has become one of the largest medical networking apps, with about 1.8 million members. Elon Musk Drops MASSIVE Bombshell The shrewd billionaire just made a VERY strange confession about the future of his electric car empire. The secret he reveals could also mint fortunes for smart, fast-moving investors. This has nothing to do with buying shares of Tesla. [Click here]( for the stunning details. Tangney aimed to fix the challenges that he noticed in the medical field. He found out through his many conversations with medical professionals that communication had become a huge barrier and that it's often stressful getting in touch with patients, other doctors, administrators, or recruiters. Tangney estimated that about 80% of communication in the industry “is done via snail mail and fax.” He commented that “software is indeed eating the world, but it kind of choked a little bit on health care.” And Doximity was created to bridge the gap and create a place to communicate. The demand was high and explains why Doximity serves more than 80% of U.S. physicians and over 90% of recent medical school graduates. Per Tangney, product development at Doximity has been centered around doctors and what they need, which explains why in the company’s IPO plans, Doximity decided to allocate 3.5 million shares of its IPO to doctors on the platform, which represented 15% of the offering. And with Doximity’s public debut success, those doctors also made a decent amount of money from the company’s IPO. Doximity’s stock surged 115% in its first two days of trading. The value of shares owned by doctors increased from $91 million to over $195 million. Tangney had this to say about this decision: Physicians are sort of outsiders in the financial markets and business world. Yet in our life and world, they’re the insiders, they’re the people we care about most. We’d rather the shares go to them if there’s a pop than to some hedge fund somewhere. Doximity cares about what it’s doing and cares about its platform's users. It isn’t interested in hyping up its business into something that it isn’t. Health care accounts for 18% of the U.S. economy, so there will always be room for Doximity to make money as long as it can keep its values and continue to expand and offer valuable features to its users. If you are interested in staying ahead and updated on companies like Doximity and their IPOs and news on the IPO market, [click here](. Until next time, [Monica Savaglia Signature Park Avenue Digest] Monica Savaglia Monica Savaglia is Wealth Daily’s IPO specialist. With passion and knowledge, she wants to open up the world of IPOs and their long-term potential to everyday investors. She does this through her newsletter [IPO Authority](, a one-stop resource for everything IPO. She also contributes regularly to the [Wealth Daily]( e-letter. To learn more about Monica, [click here](. Browse Our Archives [I Hit a Tesla This Morning, and I Liked It... Again]( [How to Make Bank in Stocks]( [Options Action Fridays — Check out This Free Trade Just for You]( [The Great Reopening, Part 1]( [How to Turn an Economic Bonanza Into Pure Profit]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2021, [Angel Publishing LLC](. All rights reserved. 3 E Read Street, Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. ---------------------------------------------------------------